Patents by Inventor Vipul YADAV

Vipul YADAV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000714
    Abstract: The present invention relates to the therapeutic uses of compositions containing antibody molecules and functional fragments thereof, e.g antibody molecules and functional fragments capable of binding to tumor necrosis factor alpha (TNF?), in the topical treatment of inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
    Type: Application
    Filed: June 12, 2023
    Publication date: January 4, 2024
    Applicants: Tillotts Pharma AG, University College London
    Inventors: Vipul YADAV, Abdul Waseh BASIT, Felipe José OLIVEIRA VARUM, Roberto Carlos BRAVO GONZALÉZ, Esther Maria FURRER
  • Publication number: 20230405081
    Abstract: A pharmaceutical composition which comprises (a) as active ingredient a peptide, and (b) an amino acid, dipeptide or a combination thereof, which act as a stabilising agent is described.
    Type: Application
    Filed: November 11, 2021
    Publication date: December 21, 2023
    Applicant: INTRACT PHARMA LIMITED
    Inventor: Vipul YADAV
  • Patent number: 11717484
    Abstract: The present invention relates to the therapeutic uses of compositions containing antibody molecules and functional fragments thereof, e.g antibody molecules and functional fragments capable of binding to tumor necrosis factor alpha (TNF?), in the topical treatment of inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: August 8, 2023
    Assignees: Tillotts Pharma AG, University College London
    Inventors: Vipul Yadav, Abdul Waseh Basit, Felipe José Oliveira Varum, Roberto Carlos Bravo Gonzaléz, Esther Maria Furrer
  • Publication number: 20220226251
    Abstract: This invention relates pharmaceutical compositions comprising a protein as the active ingredient together with one or more dipeptides as stabilising agents, and optionally an enzyme inhibitor. The compositions are particularly useful for administration to the intestinal tract.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 21, 2022
    Inventors: Abdul Waseh Basit, Vipul Yadav
  • Publication number: 20220202730
    Abstract: The present invention relates to the therapeutic use of compositions containing 5-aminolevulinic acid for the local treatment of inflammatory bowel disease, including but not restricted to ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: April 29, 2020
    Publication date: June 30, 2022
    Inventors: Abdul Waseh Basit, Vipul Yadav, Satofumi Kawata, Motoyasu Tomioka, Yasufumi Wada
  • Publication number: 20200170956
    Abstract: The present invention relates to the therapeutic uses of compositions containing antibody molecules and functional fragments thereof e.g antibody molecules and functional fragments capable of binding to tumor necrosis factor alpha (TNF?), in the topical treatment of inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
    Type: Application
    Filed: April 26, 2018
    Publication date: June 4, 2020
    Applicants: Tillotts Pharma AG, University College London
    Inventors: Vipul YADAV, Abdul Waseh BASIT, Felipe José OLIVEIRA VARUM, Roberto Carlos BRAVO GONZALÉZ, Esther Maria FURRER